The Combination of 18F-FDG PET/CT Imaging and Its Guided Tissue Core Biopsy in Differentiating Malignant from Benign Lesions

孙龙,官泳松,方亚,潘卫民,陈贵兵,罗作明,魏继宏,吴华

DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2008.06.009

2008-01-01

Abstract:Objective It is well known that 18F-fluorodeoxyghicose (FDG) PET/CT might have false-positive and false-negative results in differentiating malignant from benign lesions. This study was to e-valuate the value of combining 18F-FDG PET/CT imaging with PET/CT guided tissue core biopsy on the same day so to improve the overall diagnostic capability. Methods Sixteen consecutive patients with de-tectable lesions underwent CT guided tissue core biopsy assisted by 18F-FDG PET/CT images after whole body PET/CT scan on a same-day protocol. The biopsy procedure took an average of 15 win. A total of 18samples were obtained for subsequent histological examinations. The final diagnosis was established by sur-gical or biopsy pathological findings and clinical follow-up. SPSS 13.0 and Fisher Exact Test were used to analyze the diagnostic ability of PET/CT alone and PET/CT combining with guided biopsy. Results Of these 16 patients, 12 were finally diagnosed as malignant and 4 as benign. Out of the 10 cases that had been considered as malignant based on 18F-FDG PET/CT scans, 8 were finally confirmed as malignant (TP) and 2 as benign (FP). Of the 6 lesions that were judged as benign on 18F-FDG PET/CT images, 2 were proven as benign (TN) and 4 as malignant (FN). Fisher's Exact Test showed that the difference between the re-suits of 18F-FDG PET/CT and tissue core biopsy was not statistically significant (P=0.604). No serious complication in biopsy was found. Conclusion The combination of 18F-FDG PET/CT and its guided tissue core biopsy may improve the diagnostic capability, especially in cases when a definitive diagnosis by PET/CT alone is difficult to make.